These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 32013927)
1. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer? Chen F; Qu M; Zhang F; Tan Z; Xia Q; Hambly BD; Bao S; Tao K BMC Cancer; 2020 Feb; 20(1):92. PubMed ID: 32013927 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of Interleukin-36s in cancers: A systematic review and meta-analysis. Zhang R; Jiang M; Huang M; Yang J; Liu Q; Zhao Z; Bai Y; He T; Zhang D; Zhang M Cytokine; 2023 Dec; 172():156397. PubMed ID: 37922622 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of IL-36 cytokines in folliculitis and eosinophilic pustular folliculitis. Sato S; Chiba T; Nakahara T; Furue M Australas J Dermatol; 2020 Feb; 61(1):e39-e45. PubMed ID: 31424098 [TBL] [Abstract][Full Text] [Related]
4. IL-34, IL-36 and IL-38 in colorectal cancer-key immunoregulators of carcinogenesis. Bao S; Hu R; Hambly BD Biophys Rev; 2020 Aug; 12(4):925-930. PubMed ID: 32638330 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-38 in colorectal cancer: a potential role in precision medicine. Chen F; Zhang F; Tan Z; Hambly BD; Bao S; Tao K Cancer Immunol Immunother; 2020 Jan; 69(1):69-79. PubMed ID: 31786620 [TBL] [Abstract][Full Text] [Related]
6. Decreased expression of interleukin-36α predicts poor prognosis in colorectal cancer patients. Wang ZS; Cong ZJ; Luo Y; Mu YF; Qin SL; Zhong M; Chen JJ Int J Clin Exp Pathol; 2014; 7(11):8077-81. PubMed ID: 25550854 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity. Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679 [TBL] [Abstract][Full Text] [Related]
8. Serum IL-36α, IL-36β, and IL-36γ levels in patients with hidradenitis suppurativa: association with disease characteristics, smoking, obesity, and metabolic syndrome. Hayran Y; Allı N; Yücel Ç; Akdoğan N; Turhan T Arch Dermatol Res; 2020 Apr; 312(3):187-196. PubMed ID: 31722038 [TBL] [Abstract][Full Text] [Related]
9. Elevated sputum IL-36 levels are associated with neutrophil-related inflammation in COPD patients. Li W; Meng X; Hao Y; Chen M; Jia Y; Gao P Clin Respir J; 2021 Jun; 15(6):648-656. PubMed ID: 33559376 [TBL] [Abstract][Full Text] [Related]
10. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis]. Wang Y; Yuan W; Ma X; Ma J Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461 [No Abstract] [Full Text] [Related]
11. Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease. Nishida A; Hidaka K; Kanda T; Imaeda H; Shioya M; Inatomi O; Bamba S; Kitoh K; Sugimoto M; Andoh A Inflamm Bowel Dis; 2016 Feb; 22(2):303-14. PubMed ID: 26752465 [TBL] [Abstract][Full Text] [Related]
12. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis. Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8 Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640 [TBL] [Abstract][Full Text] [Related]
14. Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome. Zhao Z; Zhang R; Gao X; Li H; Liu H Medicine (Baltimore); 2020 Dec; 99(52):e23832. PubMed ID: 33350771 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-36β provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responses. Milora KA; Uppalapati SR; Sanmiguel JC; Zou W; Jensen LE Sci Rep; 2017 Jul; 7(1):5799. PubMed ID: 28724920 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2. Aoyagi T; Newstead MW; Zeng X; Nanjo Y; Peters-Golden M; Kaku M; Standiford TJ PLoS Pathog; 2017 Nov; 13(11):e1006737. PubMed ID: 29166668 [TBL] [Abstract][Full Text] [Related]
17. IL-36 signaling pathway dysregulation in Crimean-Congo hemorrhagic fever virus patients: A potential therapeutic avenue. Doğan K; Büyüktuna SA J Med Virol; 2024 Jan; 96(1):e29347. PubMed ID: 38152020 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability. Joo YH; Kim HK; Hak Choi I; Han HM; Lee KJ; Kim TH; Lee SH Cytokine; 2020 Jan; 125():154798. PubMed ID: 31430658 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer. Zeng J; Tang ZH; Liu S; Guo SS World J Gastroenterol; 2017 Mar; 23(10):1780-1786. PubMed ID: 28348483 [TBL] [Abstract][Full Text] [Related]
20. Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity. Yang CS; Zhang QX; Deng Y; Zhou BJ; Zhang LJ; Li LM; Qi Y; Wang J; Yang L; Shi FD BMC Neurol; 2019 Aug; 19(1):185. PubMed ID: 31382910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]